Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.870
-0.250 (-11.79%)
At close: Mar 28, 2025, 4:00 PM
1.702
-0.168 (-8.98%)
After-hours: Mar 28, 2025, 7:55 PM EDT
SKYE's stock price has decreased by -86.96% in the past year and price targets may not have had time to catch up.
Skye Bioscience Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$18.00
Upside
+862.57%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +648.66% | Mar 21, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $15 | Buy | Reiterates | $15 | +702.14% | Mar 21, 2025 |
William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 28, 2025 |
Scotiabank | Scotiabank | Buy Initiates $20 | Buy | Initiates | $20 | +969.52% | Sep 30, 2024 |
Piper Sandler | Piper Sandler | Buy Reiterates $20 | Buy | Reiterates | $20 | +969.52% | Sep 20, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +648.66% | Sep 20, 2024 |
JMP Securities | JMP Securities | Buy Initiates $15 | Buy | Initiates | $15 | +702.14% | Sep 10, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +648.66% | Sep 9, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +648.66% | Sep 6, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +648.66% | Aug 27, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +862.57% | Jul 9, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +648.66% | Jul 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +648.66% | Jun 18, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +648.66% | Jun 17, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $21 | Buy | Initiates | $21 | +1,022.99% | May 23, 2024 |
Oppenheimer | Oppenheimer | Buy Initiates $25 | Buy | Initiates | $25 | +1,236.90% | Apr 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.